Ross Chambers

1.1k total citations
21 papers, 919 citations indexed

About

Ross Chambers is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Ross Chambers has authored 21 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Ross Chambers's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and RNA Research and Splicing (4 papers). Ross Chambers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and RNA Research and Splicing (4 papers). Ross Chambers collaborates with scholars based in United States, New Zealand and Italy. Ross Chambers's co-authors include Michael Dahmus, Caroline M. Kane, Stephen Albert Johnston, Zachary F. Burton, S. Chatterjee, Richard J. Whitley, G. Yancey Gillespie, Liliana Soroceanu, Bernard Roizman and Samita Andreansky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ross Chambers

20 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Chambers United States 13 689 178 137 125 101 21 919
David Poon United States 19 1.2k 1.8× 231 1.3× 195 1.4× 88 0.7× 97 1.0× 29 1.5k
Leonardo G. Alonso Argentina 17 543 0.8× 122 0.7× 177 1.3× 99 0.8× 64 0.6× 36 792
Guy de Martynoff Belgium 10 422 0.6× 124 0.7× 104 0.8× 47 0.4× 123 1.2× 16 705
Catherine Moss United Kingdom 15 551 0.8× 102 0.6× 160 1.2× 78 0.6× 49 0.5× 27 919
Rituparna Mukhopadhyay United States 14 878 1.3× 298 1.7× 49 0.4× 155 1.2× 44 0.4× 27 1.1k
Nicholas Flint Switzerland 11 617 0.9× 188 1.1× 176 1.3× 109 0.9× 82 0.8× 20 1.0k
Tasuku Kitada United States 13 1.1k 1.6× 179 1.0× 82 0.6× 131 1.0× 27 0.3× 17 1.3k
Martijn J. W. E. Rabelink Netherlands 16 599 0.9× 384 2.2× 109 0.8× 193 1.5× 26 0.3× 30 855
Franz Hofer Austria 8 700 1.0× 51 0.3× 197 1.4× 82 0.7× 31 0.3× 21 1.1k
Cheng‐Yu Chung United States 19 572 0.8× 131 0.7× 72 0.5× 52 0.4× 258 2.6× 29 787

Countries citing papers authored by Ross Chambers

Since Specialization
Citations

This map shows the geographic impact of Ross Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Chambers more than expected).

Fields of papers citing papers by Ross Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Chambers. The network helps show where Ross Chambers may publish in the future.

Co-authorship network of co-authors of Ross Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Chambers. A scholar is included among the top collaborators of Ross Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Chambers. Ross Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogers, Daniel H., Ileine M. Sanchez, Alexandra Snyder, et al.. (2025). Abstract 3406: GPRC5D multispecific antibodies with potent anti-tumor activity against multiple myeloma. Cancer Research. 85(8_Supplement_1). 3406–3406. 1 indexed citations
2.
Banik, Soma S. R., Natasha Kushnir, Benjamin J. Doranz, & Ross Chambers. (2023). Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets. mAbs. 15(1). 2273018–2273018. 3 indexed citations
3.
Rucker, Joseph, Ileine M. Sanchez, Anna Lobley, et al.. (2023). 1183 Development of CTIM-76, a highly specific Claudin 6 bispecific antibody. SHILAP Revista de lepidopterología. A1304–A1304. 1 indexed citations
4.
Rucker, Joseph, Ileine M. Sanchez, Anna Lobley, et al.. (2023). Abstract 1865: Development of CTIM-76, a highly specific Claudin 6 bispecific antibody for treatment of ovarian cancer. Cancer Research. 83(7_Supplement). 1865–1865.
5.
Stafford, Lewis J., Trevor Barnes, Rebecca N. Wright, et al.. (2022). Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point. iScience. 25(12). 105665–105665. 9 indexed citations
6.
Davidson, Edgar, Kathryn E. Kadash-Edmondson, Ross Chambers, et al.. (2022). Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Cell Reports. 39(8). 110859–110859. 14 indexed citations
7.
Tucker, David, Jonathan T. Sullivan, Christine R. Fisher, et al.. (2018). Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles. Proceedings of the National Academy of Sciences. 115(22). E4990–E4999. 48 indexed citations
8.
Brown, Michael S., Lewis J. Stafford, Dale V. Onisk, et al.. (2013). Snorkel: An Epitope Tagging System for Measuring the Surface Expression of Membrane Proteins. PLoS ONE. 8(9). e73255–e73255. 10 indexed citations
9.
Brown, Michael C., Ross Chambers, Dale V. Onisk, et al.. (2011). Impact of Immunization Technology and Assay Application on Antibody Performance – A Systematic Comparative Evaluation. PLoS ONE. 6(12). e28718–e28718. 32 indexed citations
10.
Chambers, Ross. (2004). High-throughput antibody production. Current Opinion in Chemical Biology. 9(1). 46–50. 25 indexed citations
11.
Chambers, Ross & Stephen Albert Johnston. (2003). High-level generation of polyclonal antibodies by genetic immunization. Nature Biotechnology. 21(9). 1088–1092. 74 indexed citations
12.
Chambers, Ross. (2003). Antibody production using genetic immunization.. PubMed. 3(18). 52–3. 1 indexed citations
13.
Chambers, Ross & Caroline M. Kane. (1996). Purification and Characterization of an RNA Polymerase II Phosphatase from Yeast. Journal of Biological Chemistry. 271(40). 24498–24504. 67 indexed citations
14.
Chambers, Ross, et al.. (1995). The Activity of COOH-terminal Domain Phosphatase Is Regulated by a Docking Site on RNA Polymerase II and by the General Transcription Factors IIF and IIB. Journal of Biological Chemistry. 270(25). 14962–14969. 107 indexed citations
15.
Chambers, Ross, G. Yancey Gillespie, Liliana Soroceanu, et al.. (1995). Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.. Proceedings of the National Academy of Sciences. 92(5). 1411–1415. 167 indexed citations
16.
Chambers, Ross & Michael Dahmus. (1994). Purification and characterization of a phosphatase from HeLa cells which dephosphorylates the C-terminal domain of RNA polymerase II. Journal of Biological Chemistry. 269(42). 26243–26248. 125 indexed citations
17.
Chambers, Ross & Patrick A. Sullivan. (1993). Expression of the exoglucanase gene in yeast and hyphal forms ofCandida albicans. FEMS Microbiology Letters. 111(1). 63–67. 13 indexed citations
18.
Chambers, Ross, et al.. (1993). An exo- -(1,3)-glucanase of Candida albicans: purification of the enzyme and molecular cloning of the gene. Journal of General Microbiology. 139(2). 325–334. 67 indexed citations
19.
Chambers, Ross, et al.. (1993). Identification of a putative active site residue in the exo‐β‐(1,3)‐glucanase of Candida albicans. FEBS Letters. 327(3). 366–369. 24 indexed citations
20.
Novy, F. G., et al.. (1953). The Rat Virus. The Journal of Infectious Diseases. 93(2). 111–123. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Poon Breakdown of academic impact, for papers by Leonardo G. Alonso Breakdown of academic impact, for papers by Guy de Martynoff Breakdown of academic impact, for papers by Catherine Moss Breakdown of academic impact, for papers by Rituparna Mukhopadhyay Breakdown of academic impact, for papers by Nicholas Flint Breakdown of academic impact, for papers by Tasuku Kitada Breakdown of academic impact, for papers by Martijn J. W. E. Rabelink Breakdown of academic impact, for papers by Franz Hofer Breakdown of academic impact, for papers by Cheng‐Yu Chung
Rankless by CCL
2026